Palvella Therapeutics PVLA Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Palvella Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The official record: Palvella Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Palvella Therapeutics's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Palvella Therapeutics's prepaid & other current?
- Palvella Therapeutics (PVLA) reported prepaid & other current of $1.38M in Q1 2026.
- How has Palvella Therapeutics's prepaid & other current changed year-over-year?
- Palvella Therapeutics's prepaid & other current decreased by 24.9% year-over-year, from $1.84M to $1.38M.
- What is the long-term trend for Palvella Therapeutics's prepaid & other current?
- Over 5 years (2020 to 2025), Palvella Therapeutics's prepaid & other current has grown at a -22.4% compound annual growth rate (CAGR), from $3.58M to $1.01M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.